Clinical Trial Update: Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143) [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating PET/CT imaging with MK-0000-143 in relapsed ovarian cancer, primary peritoneal cancer, and fallopian tube cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• MK-0000-143

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ovarian Cancer, Primary Peritoneal Cancer | Phase 1 | Status: COMPLETED